Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neratinib and the Role of Anti-HER2 Therapy in Salivary Duct Carcinoma.
Napolitano M, Trudu L, Martinelli E, Santini C, Dominici M, Bertolini F. Napolitano M, et al. Among authors: dominici m. Cancer Rep (Hoboken). 2025 Jan;8(1):e70065. doi: 10.1002/cnr2.70065. Cancer Rep (Hoboken). 2025. PMID: 39814370 Free PMC article.
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC.
Lo Tartaro D, Aramini B, Masciale V, Paschalidis N, Lofaro FD, Neroni A, Borella R, Santacroce E, Ciobanu AL, Samarelli AV, Boraldi F, Quaglino D, Dubini A, Gaudio M, Manzotti G, Reggiani F, Torricelli F, Ciarrocchi A, Neri A, Bertolini F, Dominici M, Filosso PL, Stella F, Gibellini L, De Biasi S, Cossarizza A. Lo Tartaro D, et al. Among authors: dominici m. Mol Cancer. 2025 Jan 14;24(1):16. doi: 10.1186/s12943-024-02209-2. Mol Cancer. 2025. PMID: 39810191 Free PMC article.
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
Canino F, Barbolini M, De Giorgi U, Fontana T, Gaspari V, Gianni C, Gianni L, Maestri A, Minichillo S, Moscetti L, Mura A, Nicoletti SVL, Omarini C, Pagani R, Sarti S, Toss A, Zamagni C, Cuoghi Costantini R, Caggia F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: dominici m. BMC Cancer. 2024 Jun 15;24(1):735. doi: 10.1186/s12885-024-12506-0. BMC Cancer. 2024. PMID: 38879498 Free PMC article.
Immunotherapy in urothelial cancer: current status and future directions.
Piombino C, Tonni E, Oltrecolli M, Pirola M, Pipitone S, Baldessari C, Dominici M, Sabbatini R, Vitale MG. Piombino C, et al. Among authors: dominici m. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(11):1141-1155. doi: 10.1080/14737140.2023.2265572. Epub 2023 Oct 27. Expert Rev Anticancer Ther. 2023. PMID: 37772970 Review.
Cerebellar metastasis of ovarian cancer: a case report.
Cabitza E, Pirola M, Baldessari C, Bernardelli G, Zunarelli E, Pipitone S, Vitale MG, Nasso C, Molinaro E, Oltrecolli M, D'Agostino E, Mandato VD, Palicelli A, Dominici M, Sabbatini R. Cabitza E, et al. Among authors: dominici m. J Med Case Rep. 2023 Dec 19;17(1):553. doi: 10.1186/s13256-023-04211-6. J Med Case Rep. 2023. PMID: 38115068 Free PMC article.
Pembrolizumab in Vaginal Carcinoma: A Case Report and Review of the Literature.
Vitale MG, Nasso C, Riccò B, Bocconi A, Chiavelli C, Baldessari C, Pipitone S, Bacchelli F, Botticelli L, Dominici M, Sabbatini R. Vitale MG, et al. Among authors: dominici m. Case Rep Oncol. 2024 Apr 20;17(1):564-572. doi: 10.1159/000535041. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 38645572 Free PMC article.
Management of PALB2-associated breast cancer: A literature review and case report.
Toss A, Ponzoni O, Riccò B, Piombino C, Moscetti L, Combi F, Palma E, Papi S, Tenedini E, Tazzioli G, Dominici M, Cortesi L. Toss A, et al. Among authors: dominici m. Clin Case Rep. 2023 Aug 22;11(8):e7747. doi: 10.1002/ccr3.7747. eCollection 2023 Aug. Clin Case Rep. 2023. PMID: 37621724 Free PMC article.
385 results